Literature DB >> 24931369

Activation of TRPV1 mediates thymic stromal lymphopoietin release via the Ca2+/NFAT pathway in airway epithelial cells.

Xinying Jia1, Hong Zhang1, Xu Cao2, Yuxin Yin1, Bo Zhang3.   

Abstract

The airway epithelium is exposed to a range of irritants in the environment that are known to trigger inflammatory response such as asthma. Transient receptor potential vanilloid 1 (TRPV1) is a Ca(2+)-permeable cation channel critical for detecting noxious stimuli by sensory neurons. Recently increasing evidence suggests TRPV1 is also crucially involved in the pathophysiology of asthma on airway epithelium in human. Here we report that in airway epithelial cells TRPV1 activation potently induces allergic cytokine thymic stromal lymphopoietin (TSLP) release. TSLP induction by protease-activated receptor (PAR)-2 activation is also partially mediated by TRPV1 channels.
Copyright © 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Asthma; Nuclear factor of activated T-cells; Protease-activated receptor-2; TRP channel; Thymic stromal lymphopoietin; Transient receptor potential vanilloid 1

Mesh:

Substances:

Year:  2014        PMID: 24931369     DOI: 10.1016/j.febslet.2014.06.018

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  15 in total

Review 1.  The importance of TSLP in allergic disease and its role as a potential therapeutic target.

Authors:  Antonella Cianferoni; Jonathan Spergel
Journal:  Expert Rev Clin Immunol       Date:  2014-11       Impact factor: 4.473

Review 2.  TRPV4 as a therapeutic target for joint diseases.

Authors:  Amy L McNulty; Holly A Leddy; Wolfgang Liedtke; Farshid Guilak
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-12-18       Impact factor: 3.000

3.  Andrographolide suppresses thymic stromal lymphopoietin in phorbol myristate acetate/calcium ionophore A23187-activated mast cells and 2,4-dinitrofluorobenzene-induced atopic dermatitis-like mice model.

Authors:  Chun-xiao Li; Hua-guo Li; Hui Zhang; Ru-hong Cheng; Ming Li; Jian-ying Liang; Yan Gu; Bo Ling; Zhi-rong Yao; Hong Yu
Journal:  Drug Des Devel Ther       Date:  2016-02-19       Impact factor: 4.162

4.  Topical Tetracycline Improves MC903-induced Atopic Dermatitis in Mice through Inhibition of Inflammatory Cytokines and Thymic Stromal Lymphopoietin Expression.

Authors:  Xiao-Jing Liu; Zhang-Lei Mu; Yan Zhao; Jian-Zhong Zhang
Journal:  Chin Med J (Engl)       Date:  2016-06-20       Impact factor: 2.628

5.  Analysis of chromatin accessibility in human epidermis identifies putative barrier dysfunction-sensing enhancers.

Authors:  Julie M Lander; Dorothy M Supp; Hua He; Lisa J Martin; Xiaoting Chen; Matthew T Weirauch; Steven T Boyce; Raphael Kopan
Journal:  PLoS One       Date:  2017-09-27       Impact factor: 3.240

6.  TRPV3 Channel in Keratinocytes in Scars with Post-Burn Pruritus.

Authors:  Chun Wook Park; Hyun Ji Kim; Yong Won Choi; Bo Young Chung; So-Youn Woo; Dong-Keun Song; Hye One Kim
Journal:  Int J Mol Sci       Date:  2017-11-15       Impact factor: 5.923

Review 7.  The emerging role of transient receptor potential channels in chronic lung disease.

Authors:  Maria G Belvisi; Mark A Birrell
Journal:  Eur Respir J       Date:  2017-08-03       Impact factor: 16.671

Review 8.  Cannabinoid-based drugs targeting CB1 and TRPV1, the sympathetic nervous system, and arthritis.

Authors:  Torsten Lowin; Rainer H Straub
Journal:  Arthritis Res Ther       Date:  2015-09-06       Impact factor: 5.156

9.  Role of the ion channel, transient receptor potential cation channel subfamily V member 1 (TRPV1), in allergic asthma.

Authors:  Katie Baker; Kristof Raemdonck; Bilel Dekkak; Robert J Snelgrove; John Ford; Fisnik Shala; Maria G Belvisi; Mark A Birrell
Journal:  Respir Res       Date:  2016-06-02

10.  The role of TRPV1 in the CD4+ T cell-mediated inflammatory response of allergic rhinitis.

Authors:  Ramachandran Samivel; Dae Woo Kim; Hye Ran Son; Yun-Hee Rhee; Eun Hee Kim; Ji Hye Kim; Jun-Sang Bae; Young-Jun Chung; Phil-Sang Chung; Eyal Raz; Ji-Hun Mo
Journal:  Oncotarget       Date:  2016-01-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.